Physician profile
David Weimer
NPI 1083825855
$1,803.71
in general payments reported to CMS, 2019-2025
13 companies · $266 in 2025
The $266 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $11.19 · 2021: $535 · 2022: $398 · 2023: $148 · 2024: $155 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $940.36 | 2019-2025 | Rosa |
| Stryker Corporation | $557.04 | 2019-2025 | Triathlon, Mako |
| Medtronic, INC. | $83.15 | 2022-2024 | V-Loc 180, Swiftset |
| Nevro Corp. | $58.46 | 2022-2024 | Senza |
| Smith+Nephew, INC. | $32.58 | 2025 | Pico 7 |
| Horizon Therapeutics Plc | $22.64 | 2019-2020 | |
| Globus Medical, INC. | $19.81 | 2025 | Senza |
| Abbott Laboratories | $19.79 | 2022 | |
| Boston Scientific Corporation | $16.55 | 2024 | Wavewriter Alpha Prime 16 |
| Pacira Pharmaceuticals Incorporated | $15.56 | 2021 | |
| Pacira Therapeutics, INC. | $14.97 | 2019 | |
| Relievant Medsystems, INC. | $11.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Weimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.